Condition: Cryptogenic Ischemic Stroke · Patent Foramen Ovale · Sponsor: Assistance Publique - Hôpitaux de Paris
To assess whether PFO closure plus antiplatelet therapy is superior to antiplatelet therapy alone and whether oral anticoagulant therapy is superior to antiplatelet therapy to prevent stroke recurrence in patients aged 60 to 80 years with a PFO with large shunt (\> 20 microbubbles) or a PFO associated with an ASA (\> 10 mm), and an otherwise unexplained ischemic stroke.
This description comes directly from the study's public registry record.
Carla Vandenabele · +331 44 84 57 27 · carla.vandenabele@aphp.fr
Malha Berrah · malha.berrah@aphp.fr
Always discuss trial participation with your own doctor first.
| CHU Amiens | Amiens, France | Recruiting |
| Centre Hospitalier de la Côte Basque | Bayonne, France | Recruiting |
| CHU Jean Minjoz | Besançon, France | Recruiting |
| CHU Bordeaux - GH Pellegrin | Bordeaux, France | Recruiting |
| CHRU La Cavale Blanche | Brest, France | Recruiting |
| HCL-Groupement Hospitalier Lyon Est | Bron, France | Recruiting |
| CHU Côte de Nacre | Caen, France | Recruiting |
| CHU Clermont Ferrand | Clermont-Ferrand, France | Recruiting |
| CH Sud Francilien | Corbeil-Essonnes, France | Recruiting |
| Hôpital Henri Mondor | Créteil, France | Recruiting |
| CHU Dijon-Hôpital François Mitterrand | Dijon, France | Recruiting |
| Hôpital Raymond Poincaré | Garches, France | Recruiting |
+ 30 more locations — full list on the registry record.
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT05387954